Dr Ward Sam(@dr_wardsam) 's Twitter Profileg
Dr Ward Sam

@dr_wardsam

MD FEBU, FECSM, Urologist, Andrologist. BHCT #MensHealth #PenileSurgery, #SexualMedicine, #Fertility EAA, ESSM, ISSM, St Jan Kliniek Brussels, Views are my own.

ID:3586991477

linkhttps://linktr.ee/dr_wardsam calendar_today08-09-2015 11:11:31

18,9K Tweets

2,2K Followers

4,9K Following

Dr Ward Sam(@dr_wardsam) 's Twitter Profile Photo

Happy Erektion Friday! Want to know more about the science of er*ctions or how lifestyle affects them? Drop your questions and shape the direction of this series! buff.ly/3SUaRgG

Happy Erektion Friday! Want to know more about the science of er*ctions or how lifestyle affects them? Drop your questions and shape the direction of this series! buff.ly/3SUaRgG #erektionfriday #sexualhealthexpert #urology #andrologist #WardOfYourHealth
account_circle
Dr Ward Sam(@dr_wardsam) 's Twitter Profile Photo

Curious about Peyronie's disease beyond the basics? It's a condition with real impact and many layers. What more do you want to learn? Share your questions and let's delve deeper together! buff.ly/3SUaRgG

Curious about Peyronie's disease beyond the basics? It's a condition with real impact and many layers. What more do you want to learn? Share your questions and let's delve deeper together! buff.ly/3SUaRgG #peyroniesdisease #menshealthexpert #urology #WardOfYourHealth
account_circle
Kari Tikkinen(@KariTikkinen) 's Twitter Profile Photo

In the Take Home Messages of , Prof Joost Boormans asked for more long term evidence with patient important outcomes for novel, already approved treatments of urothelial cancer

In the Take Home Messages of #EAU24, Prof Joost Boormans asked for more long term evidence with patient important outcomes for novel, already approved treatments of urothelial cancer #EBM
account_circle
UroToday.com(@urotoday) 's Twitter Profile Photo

Two-year QoL outcomes of the randomized phase II trial : neoadjuvant degarelix with or without apalutamide prior to radical prostatectomy for high-risk . Presented by Alexander Giesen UZ Leuven. written coverage by Rashid K. Sayyid University of Toronto > bit.ly/4aMspSa

Two-year QoL outcomes of the randomized phase II trial #ARNEO: neoadjuvant degarelix with or without apalutamide prior to radical prostatectomy for high-risk #ProstateCancer. Presented by @TheGiesen @UZLeuven. #EAU24 written coverage by @RKSayyid @UofT > bit.ly/4aMspSa
account_circle
Mikkel Fode(@MikkelFode) 's Twitter Profile Photo

A narrative review on a subject our group started studying some years ago. In clinical practice these side effects remain neglected and comes as a surprise to many survivors

account_circle
UROLOGY CHEAT SHEETS(@CheatUrology) 's Twitter Profile Photo

Excited to unveil our latest : A for Urological Conditions, from idiopathic overactive bladder to neurogenic detrusor overactivity!
Created by Daniel Pérez Fuentes and DAVID CARRACEDO CALV.

Thank you very much for this excellent work! ROC Clinic

Excited to unveil our latest #UrologyCheatSheet: #BotulinumToxin A for Urological Conditions, from idiopathic overactive bladder to neurogenic detrusor overactivity! Created by @danielo_1995 and @DavidCarracedoC. Thank you very much for this excellent work! @ROC_Urologia
account_circle
Gaëtan Devos(@devos_gaetan) 's Twitter Profile Photo

Today we presented the 3 year oncological outcomes of the ARNEO trial:
- Patients treated with 3 mo neoadjuvant ADT + Apalutamide have tendency towards improved BCR free and metastasis free survival.
- pT2 disease associated with less biochemical recurrence.
steven joniau Alexander Giesen

account_circle
Maria J. Ribal(@MariaJRibal) 's Twitter Profile Photo

And Here they are!!!!! We hope you find them useful and a good tool for helping you in your daily practice. This is the idea behind. Again all my gratitude to staff and members.! I’m a lucky person to work I such amazing family.!

account_circle
Benoît Peyronnet(@BPeyronnet) 's Twitter Profile Photo

I can’t believe I am actually seeing this!! 6 months outcomes of the electromechanical artificial sphincter in the first 6 male patients presented by chartier-kastler e and the first woman has already been implanted! The future is here!!

I can’t believe I am actually seeing this!! #EAU24 6 months outcomes of the electromechanical #uromems artificial sphincter in the first 6 male patients presented by @echartierkastle and the first woman has already been implanted! The future is here!!
account_circle
Woodson Smelser, MD(@WSmelser) 's Twitter Profile Photo

Always a great discussion with world-expert Rachel S. Rubin, MD who gave updates in female sexual medicine at the 2024 Missouri/Kansas Urologic Meeting. Many germane topics for both benign urologists and oncologists alike.

Always a great discussion with world-expert @drrachelrubin who gave updates in female sexual medicine at the 2024 Missouri/Kansas Urologic Meeting. Many germane topics for both benign urologists and oncologists alike.
account_circle
Pieter De Backer(@pidebacker) 's Twitter Profile Photo

Personal highlight seeing my two longtime mentors side by side performing AI assisted live surgeries on NVIDIA AI holoscan as developed at Orsi Innotech. AR guided surgery on the left by Karel Decaestecker and realtime out-of-body anonymization on the right by Alex Mottrie

Personal #EAU24 highlight seeing my two longtime mentors side by side performing AI assisted live surgeries on @NVIDIAAI holoscan as developed at @Orsi_Innotech. AR guided surgery on the left by @KarelDecaestec1 and realtime out-of-body anonymization on the right by @alexmottrie
account_circle
Wai Gin (Don) Lee(@donwglee) 's Twitter Profile Photo

Fantastic talk by Gunter De Win in managing the extrophy penis but first understand what challenges the patient really faces. Just changing sexual positions can help!

Fantastic talk by @GunterDeWin in managing the extrophy penis but first understand what challenges the patient really faces. Just changing sexual positions can help!
account_circle